StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) income statement

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$145.14+1.86 (+1.30%)

Close on Nov 18, 2026Market cap $19.48BP/E –Yield –

Guardant Health, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
65.0%
Operating margin
-39.7%
Net margin
-38.3%
Return on equity, FY2025
348.4%

Financial strength

Current ratio
4.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
310.8%

Valuation

P/E ratio
–
Price to sales
16.46
Price to book
–
Dividend yield
–

See a number that looks wrong?